Acts as a gene switch helping to regulate the activity of the PARATHYROID and production of calcium in the blood and bones. It is good for treating hyperparathyroidism and hypoparathyroidism as well as those suffering from osteoporosis and poor vitamin D absorption. In addition it helps to reduce bone demineralisation, urolithiasis disease, muscle cramps and to improve immunity.
The typical way to dose any peptide bioregulator is to initially take an ‘intensive’ course which is 2 capsules a day for 30-days (60 capsules) and then follow every 3 months with 2 capsules a day for 10-days (20 capsules). Therefore, the ‘average person’ requires 120 capsules of a peptide bioregulator for a year.
In some cases, where there is a more severe need, the repeat regime can be increased to 20-capsules every 2-months, or even every month. These amended doses can only be judged in practice and for the need of the individual.
Regulation of the parathyroid function
(State Registration Certificate № RU.77.99.11.003.Е. 008875.10.14)
Ingredients: peptide complex A-21 (parathyroid glands peptides); microcrystalline cellulose (E460, flowing agent); gelatin ( encapsulating agent); lactose (excipient-humectant); calcium stearate (E470, emulsifier); titanium dioxide (E171, colour for capsules)
Bonotirk® – is a peptidecomplex isolated from the parathyroid glands of young animals. Isolated peptides act selectively on the functional activity of the parathyroid glands cells, normalize their metabolism.
Clinical studies revealed the efficiency of Bonotirk ® in the complex treatment of the osteoporosis, as well as in aging to support locomotor system function.
No side effects.
Contraindications: individual intolerance, pregnancy, breast-feeding.
Bonotirk ® is recommended to be taken with meals, 1-2 capsules 1-2 times a day for 30 days. A repeated course is advisable in 4-6 months.
MADE IN RUSSIA